Table 4: Comparison between HCV patients with high and low serum TC.

TC 177 mg/dL (Range or %) 177 mg/dL(Range or %) value

Total5050
Age (y.o.)57(24–78)57(36–69)NS
Sex (%)
 Male34(68)20(40)
 Female16(32)30(60)0.005
BMI (kg/m2)21.5(18.4–26.8)23.5(15.4–30.6)0.027
WBC (/ L)5100(2100–9730)5100(3000–8300)NS
Hemoglobin (g/dL)14.2(10–16)13.9(10–16)NS
Platelet (104/ L)17.6(7.3–26.5)21.7(6.9–26.1)NS
AST (IU/L)48(17–377)33(18–199)0.033
ALT (IU/L)67(16–751)40(11–283)NS
TG (mg/dL)83(46–203)111(43–262)NS
88 mg/dL (%)32(63)19(38)
88 mg/dL (%)18(37)31(62)0.045
LDL-C (mg/dL)84(43–118)121(30–167) 0.001
98 mg/dL (%)40(79)9(19)
98 mg/dL (%)10(21)41(81) 0.001
HCV RNA (KIU/mL)1000(20–24200)2670(20–40900)0.029
Distribution of stage of fibrosis (%)
 118(36)25(50)
 27(14)10(20)
 38(16)3(6)
 42(4)2(4)
 Unknown15(30)10(20)NS
Distribution of grade of inflammation (%)
 120(40)19(38)
 214(28)20(40)
 31(2)1(2)
 Unknown15(30)10(20)NS

Data are median (range) or frequency (%).